Valuation: Renalytix Plc

Market Cap 42.35M 38.61M 35.74M 32.36M 60.72M 3.95B 63.68M 431M 171M 2.14B 159M 156M 6.76B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 37.13M 33.85M 31.33M 28.37M 53.23M 3.46B 55.83M 378M 150M 1.88B 139M 136M 5.93B EV / Sales 2026 *
9.28x
EV / Sales 2027 * 3.79x
Free-Float
81.69%
Yield 2026 *
-
Yield 2027 * -
1 week-0.93%
Current month-1.83%
1 month-1.83%
3 months+35.44%
6 months+197.22%
Current year-9.32%
1 week 5.15
Extreme 5.15
5.6
1 month 5.15
Extreme 5.15
6.1
Current year 1.6
Extreme 1.6
6.57
1 year 1.6
Extreme 1.6
7
3 years 1.6
Extreme 1.6
74.9
5 years 1.6
Extreme 1.6
725.96
10 years 1.6
Extreme 1.6
1,220
Manager TitleAgeSince
Chief Executive Officer 58 14/03/2018
Director of Finance/CFO 68 27/05/2024
President 65 29/04/2024
Director TitleAgeSince
Director/Board Member 58 14/03/2018
Chairman 74 -
Director/Board Member 59 14/03/2018
Date Insider Type Main position Quantity % Market Cap. Importance
13/02/26 Buy

Founder

250 0.0001%
13/02/26 Buy

Chief Financial Officer

500 0.0001%
13/02/26 Buy

Founder

500 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.93%-26.21%-78.16% 42.45M
-0.58%-4.04%+19.57%+47.67% 257B
-0.45%-3.29%+0.91%+9.52% 161B
-3.26%-9.41%-25.52%+33.40% 146B
-1.49%-4.74%-56.67%-20.89% 63.26B
-1.28%-1.82%+23.61%+55.28% 60.51B
-0.05%+0.69%+5.41%-12.43% 53.46B
-1.12%-0.91%+21.90%+54.96% 49.99B
-5.15%-13.73%-3.95%+48.93% 44.88B
-2.06%-3.06%+21.20%+74.31% 45.81B
Average -1.26%-3.15%-1.97%+21.26% 88B
Weighted average by Cap. -0.95%-3.95%+1.66%+32.16%

Financials

2026 *2027 *
Net sales 4M 3.65M 3.38M 3.06M 5.74M 373M 6.02M 40.73M 16.16M 202M 15M 14.69M 639M 12.95M 11.81M 10.93M 9.9M 18.57M 1.21B 19.48M 132M 52.31M 655M 48.58M 47.57M 2.07B
Net income -19.74M -18M -16.66M -15.08M -28.3M -1.84B -29.69M -201M -79.74M -998M -74.04M -72.51M -3.15B -10.99M -10.02M -9.28M -8.4M -15.76M -1.03B -16.53M -112M -44.4M -556M -41.22M -40.37M -1.76B
Net Debt -5.22M -4.76M -4.41M -3.99M -7.48M -487M -7.85M -53.16M -21.09M -264M -19.58M -19.17M -834M 6.68M 6.09M 5.64M 5.1M 9.58M 623M 10.05M 68.02M 26.99M 338M 25.06M 24.54M 1.07B
Projected Income Statement - Annual - Renalytix Plc
Logo Renalytix Plc
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Employees
46
Date Price Change Volume
19/11/26 GBX 5.350 0.00% 589,176
18/11/26 GBX 5.350 0.00% 56,501
17/11/26 GBX 5.350 -0.93% 646,273
16/11/26 GBX 5.400 0.00% 46,134
13/11/26 GBX 5.400 0.00% 193,359

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Renalytix Plc
  1. Stock Market
  2. Stocks
  3. RENX Stock